ALEXANDER IMAS: Open Payments
NPI 1114901444 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,150 in 112 payments from 14 companies in 2025. Trend: 2023 $13,389 · 2024 $1,996 · 2025 $2,150
Food & beverage: $2,150
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 24 | $384 |
| ABBVIE INC. | 21 | $341 |
| Indivior Inc. | 14 | $340 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $304 |
| PFIZER INC. | 12 | $228 |
| Orexo US, Inc. | 7 | $156 |
| Braeburn Inc. | 6 | $136 |
| Forte Bio-Pharma LLC | 5 | $113 |
| SCILEX PHARMACEUTICALS INC. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $31 |
Products named: SUBLOCADE, RELISTOR, NURTEC ODT, Belbuca, UBRELVY, Zubsolv, QULIPTA, BRIXADI.
Industry payments across NV — which companies pay providers there.
